|
n (%)
|
38 (18)
|
113 (54)
|
-
|
64 (31)
|
54 (26)
|
90 (43)
|
-
|
|
Glucose lowering treatment
| | | | | | | |
|
Metformin, n (%)
|
0 (0)
|
1 (0.9)
|
0.748
|
0 (0)
|
1 (2)
|
64 (71)
|
<0.001*
|
|
Sulfonylurea, n (%)
|
0 (0)
|
1 (0.9)
|
0.748
|
0 (0)
|
0 (0)
|
1 (1)
|
<0.001*
|
|
Insulin therapy, n (%)
|
0 (0)
|
0 (0)
|
-
|
0 (0)
|
0 (0)
|
24 (34)
|
<0.001*
|
|
Thiazolidinediones, n (%)
|
0 (0)
|
0 (0)
|
-
|
0 (0)
|
0 (0)
|
2 (2)
|
0.266
|
|
Glinide, n (%)
|
0 (0)
|
0 (0)
|
-
|
0 (0)
|
0 (0)
|
2 (2)
|
0.266
|
|
Hypertension treatment
| | | | | | | |
|
Beta-blocker, n (%)
|
23 (61)
|
72 (63)
|
0.434
|
33 (52)
|
39 (72)
|
62 (69)
|
0.033*
|
|
AT1 receptor blocker, n (%)
|
5 (13)
|
16 (14)
|
1.000
|
9 (14)
|
6 (11)
|
15 (17)
|
0.653
|
|
ACE-inhibitor, n (%)
|
24 (36)
|
65 (58)
|
0.573
|
31 (48)
|
37 (69)
|
55 (61)
|
0. 076
|
|
Calcium antagonist, n (%)
|
7 (18)
|
18 (16)
|
0.801
|
9 (14)
|
6 (11)
|
23 (26)
|
0.055
|
|
Diuretics, n (%)
|
12 (32)
|
31 (27)
|
0.679
|
16 (25)
|
16 (30)
|
31 (34)
|
0.450
|
|
Other Medications
| | | | | | | |
|
Nitrate, n (%)
|
5 (13)
|
7 (6)
|
0.181
|
1 (2)
|
7 (13)
|
16 (18)
|
0.008*
|
|
Acetyl salicylic acid, n (%)
|
24 (63)
|
76 (68)
|
0.691
|
38 (60)
|
40 (74)
|
65 (73)
|
0.169
|
|
Clopidrogel, n (%)
|
11 (29)
|
34 (31)
|
1.000
|
13 (21)
|
18 (33)
|
28 (32)
|
0.259
|
|
Allopurinol, n (%)
|
5 (13)
|
6 (5.4)
|
0.147
|
3 (5)
|
3 (6)
|
15 (17)
|
0.022*
|
|
Aldosterone antagonist, n (%)
|
1 (3)
|
0 (0)
|
0.248
|
0 (0)
|
1 (2)
|
0 (0)
|
0.245
|
|
Statin, n (%)
|
16 (42)
|
60 (53)
|
0.423
|
27 (42)
|
28 (52)
|
49 (55)
|
0.598
|
